Which has the lower trailing P/E, MEDP or SOLV?

SOLV has the lower trailing P/E: MEDP trades at 33.81 and SOLV at 10.46. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MEDP or SOLV?

Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus SOLV at 2.72%.

Is MEDP or SOLV more profitable?

MEDP runs the higher net margin — MEDP at 17.67% versus SOLV at 17.33%.

Medpace Holdings, Inc. (MEDP) vs Solventum Corporation (SOLV)

A side-by-side comparison of Medpace Holdings, Inc. and Solventum Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

MEDP

Medpace Holdings, Inc.

$16.11B

$577.11HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

SOLV

Solventum Corporation

$14.80B

$85.44HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

Total return — MEDP vs SOLV

growth of $100 · dividends reinvested · last 2y

MEDP +43.3%SOLV +6.8%MEDP compounded faster

MEDP SOLV

MEDP vs SOLV: by the numbers

•MEDP is the larger company ($16.11B vs $14.80B market cap).
•SOLV trades at the lower trailing earnings multiple (10.46 vs 33.81 P/E), one valuation lens rather than an overall verdict.
•MEDP converts more revenue to profit (17.67% vs 17.33% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs 2.72% CAGR).

Metrics side by side

Valuation

Metric	MEDP	SOLV
P/E ratio	33.81	10.46
Forward P/E	32.79	13.04
P/S ratio	5.97	1.81
P/B ratio	38.26	3.02
PEG ratio	1.82	0.04
EV / EBITDA	27.14	6.80
FCF yield	4.42%	N/A

Profitability

Metric	MEDP	SOLV
Gross margin	28.76%	53.67%
Operating margin	20.97%	25.54%
Net margin	17.67%	17.33%
ROE	113.29%	28.82%
ROIC	67.94%	17.76%

Growth (annualized)

Metric	MEDP	SOLV
Revenue CAGR (5Y)	22.03%	2.72%
EPS CAGR (5Y)	30.90%	6.26%
FCF CAGR (5Y)	23.40%	N/A
Total return CAGR (5Y)	26.81%	N/A

Frequently asked

Which has the lower trailing P/E, MEDP or SOLV?: SOLV has the lower trailing P/E: MEDP trades at 33.81 and SOLV at 10.46. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MEDP or SOLV?: Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus SOLV at 2.72%.
Is MEDP or SOLV more profitable?: MEDP runs the higher net margin — MEDP at 17.67% versus SOLV at 17.33%.

Go deeper

Full MEDP analysis Full SOLV analysis Interactive comparison tool

Dig into the metrics

Medpace P/E ratio Solventum P/E ratio Medpace dividend yield Solventum dividend yield Medpace ROE Solventum ROE Medpace operating margin Solventum operating margin Medpace revenue growth Solventum revenue growth Medpace free cash flow Solventum free cash flow

Medpace & Solventum appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.